Our consultants

During your diagnosis and treatment within the Edinburgh Cancer Centre you will meet lots of different health care professionals. One member of the team who will be closely involved in your care throughout your cancer journey will be the Clinical Nurse Specialist(CNS).

The Clinical Nurse Specialist is an experienced registered nurse with advanced specialist knowledge and education in cancer and cancer treatments. They act as a point of contact for you and the people close to you and can provide emotional support, clinical expertise, and specialist advice on cancer treatment and any symptoms that you may have.

You will initially meet the Clinical Nurse Specialist when you come to see the Consultant at the time of your diagnosis. They will then become more involved with managing your symptoms and side effects of treatments once your cancer treatments has started. This is because they are highly skilled and can assess your needs and make treatment recommendations. This will  be carried out in their own clinics or over the phone with you whilst you are at home.

A diagnosis of cancer can be life- changing for you and the people close to you. The Clinical Nurse Specialists role is to be there to listen to you and help support you and your family and to find out what matters to you. They will help you to make sense of a large amount of unfamiliar information and support you with the decisions you make around your care. To ensure your health care needs are met, the Clinical Nurse Specialist will work closely with other health care professionals in the hospital as well as the community such as GPs, district nurses and dieticians.

Our aim is to provide high quality individualised patient centred care during and after your cancer treatments.

Bio To Follow

Bio To Follow

Bio To Follow

Dr Noble is a Consultant Clinical Oncologist at the Edinburgh Cancer Centre (ECC), Honorary Senior lecturer with Edinburgh University, NHS Scotland NRS Research Fellow, and Assistant Editor for Cinical Oncology. He completed undergraduate medical studies at the University of Cambridge, and trained as a Clinical Oncologist in the East of England, based at the Cambridge Cancer Centre. During training, Dr Noble won a 3-year Cancer Research UK Clinical Research Fellowship and completed a PhD investigating technical aspects of Adaptive Radiotherapy for Head & Neck Cancer, and moved to Edinburgh to take up a Consultant post in August 2020.

Dr Noble specialises in treating Head & Neck Cancer, and has an academic interest in advanced imaging, image analysis, and radiotherapy treatment techniques, biomarkers of disease and normal tissue response to radiation, and data science across all tumour types. He has an active portfolio of basic and translational research projects, works closely within the Edinburgh Radiotherapy Research Group led by Professors Duncan McLaren and Bill Nailon, with ENT colleagues from the ECC Head & Neck Unit including Mr Iain Nixon, and with Radiologist Dr Rishi Ramaesh. Projects funded by the Scottish Chief Scientists Office (CSO) include IMAGINE (grant no: TCS/17/26) – in which advanced radiomics and machine learning techniques are applied to on-treatment image guidance (IG) scans to look for predictors of more severe toxicity, PRISTINE (grant no: TCS/21/39), in which Scotlands only PET-MRI machine will be used to improve staging and treatment personalisation for men with high-risk early prostate cancer, and SR-1171 in which circulating tumour DNA is used to assess and monitor treatment response in patients who have undergone curative treatment for HPV-driven Head & Neck Cancer. In the PROSECCA project, funded by Prostate Cancer UK (grant no: MA-CT20-010), the research team aim to collate longitudinal health records, disease data, and radiotherapy planning and imaging data for all Scottish men who have been treated with IMRT to improve our ability to predict treatment response and side effects.

Dr Noble has a number of external collaborators including Dr. Claire Patterson and Professor Gareth Inman from the Beatson Cancer Centre in Glasgow - looking at using a combination of MRI imaging features, and genomic analysis to improve our ability to predict poor treatment response in high-risk oropharyngeal cancer, and with Dr Raj Jena from the Cambridge Cancer Centre in the CRUK-funded HAMLET study – the first propsective analysis of machine learning predictive models in radiation therapy. In addition, he works closely within the ECC Head & Neck trials team, led by Dr Devraj Srinivasan, which recruits extensively to national and international trials including COMPARE, PATHOS, POPPY, BURAN, and VERSATILE. Dr Noble would be please to discuss proposals for projects, trials, supervision, and further collaboration.

Dr Stillie is a Clinical Oncology Consultant and Honorary Senior Lecturer at the University of Edinburgh specialising in the management of gynaecological malignancies with radiotherapy, brachytherapy and systemic anti cancer treatment and involved in clinical trials . In addition to her clinical practice she has local and national roles in education and training in the undergraduate and postgraduate setting. She is a Clinical and Educational Supervisor for Clinical Fellows and Speciality Trainees in Oncology at the Edinburgh Cancer Centre, oversees the oncology component of the MBChB Curriculum, and is a Lead for Undergraduate Medical Education in NHS Lothian. At a national level she is a Senior Examiner and Deputy Chair for the Royal College of Radiologists FRCR examination board and a founding member of the RCR undergraduate committee. In addition, she is the deputy chair of the Gynaecology South East Scotland Cancer Network.

Dr Macnair graduated from Newcastle University in 2009 with merit. Following University, he trained down in London completing his MRCP in 2012 prior to starting his specialist training. His specialist clinical oncology training was based in South London at the Royal Marsden, Sussex Cancer Centre and also Imperial College London. He passed his FRCR in 2017. He has completed an MD with UCL in clinical trial methodology while he worked as a clinical research fellow at the MRC clinical trials unit. He also took a year out of training to do a year with the Faculty of Medical Leadership and Management. During this year he worked jointly at Macmillan Cancer Support and the Royal College of Radiologists. He completed his final year of training in the Edinburgh Cancer Centre before starting as a consultant.

Dr Mackenzie studied medicine at the University of Dundee, graduating in 2003 with and MB ChB and BMedSci. She was a junior doctor in Edinburgh, Fife and Dundee before starting specialty training in Clinical Oncology in Edinburgh in 2008. During her training she developed a special interest in head and neck cancers and after completing specialty training undertook a fellowship in Calgary, Canada. During her fellowship she focused on head and neck and skin cancers and developed a special interest in peer review of radiotherapy planning. She returned from Canada to start her consultant post in 2015. Her consultant role involves treatment of head and neck and skin cancers with both radiotherapy and drug therapies. She is involved in clinical trials for both patient groups. Dr Mackenzie is lead oncologist for SCAN for head and neck cancer and was part of the RCR working group publishing guidelines on peer review in radiotherapy planning.

Dr Law has been a Consultant in Clinical Oncology at Edinburgh Cancer Centre since 2011 having completed a fellowship at Peter Maccallum Cancer Centre in Melbourne before that. He has an interest in urological cancers particularly testes cancer and also brachytherapy for prostate cancer. He is  involved in education and acts as college tutor, educational and clinical supervisor for the clinical oncology trainees. Dr Law is also involved in clinical trials and also one of the organisers of the Edinburgh Oncology course and the pan-Scotland teaching for oncology trainees.